发明名称 |
Use of tyrosine kinase inhibitors for the treatment of inflammatory processes |
摘要 |
The present invention relates to the use of selected quinazolines, the tautomers, stereoisomers and salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, for preparing a pharmaceutical composition for the prevention or treatment of diseases of the airways or lungs as well as other inflammatory diseases.
|
申请公布号 |
US2005059661(A1) |
申请公布日期 |
2005.03.17 |
申请号 |
US20040899817 |
申请日期 |
2004.07.27 |
申请人 |
BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
发明人 |
JUNG BIRGIT;PUESCHNER HUBERT |
分类号 |
A61K31/517;A61K31/5377;(IPC1-7):A61K31/537 |
主分类号 |
A61K31/517 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|